Assessing the Immunogenicity of pING-hHER3FL
Clinical trial NCT03832855 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03832855
- Sponsor
- Herbert Lyerly
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-13
- Primary completion
- 2026-03-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.